IQLung

IQLung is a French health technology company specializing in artificial intelligence and radiomics for precision oncology, specifically targeting lung cancer. The company develops AI-driven diagnostic tools that analyze medical imaging and clinical data to predict patient response to treatments such as immunotherapy and chemotherapy. By integrating multi-modal data, IQLung aims to assist oncologists in personalizing therapeutic strategies and improving clinical outcomes for patients with non-small cell lung cancer. Their platform facilitates early diagnosis and provides longitudinal monitoring of treatment efficacy through advanced image analysis. The company's technology is designed to optimize the use of immune checkpoint inhibitors by identifying patients most likely to benefit from these therapies.